Patent · US Active

Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma

US8668901B2 · kind B2 · utility

9Cited by

7References

22Claims

0Family size

Assignee

Activaero GmbH Research & Development · DE

Inventors

Bernard Muellinger · Munich, DE
Gerhard Scheuch · Kirchberg, DE
Thomas Hofmann · Doylestown, US
Philipp Kroneberg · Olching, DE

Key dates

Filing date	Feb 3, 2010
Grant date	Mar 11, 2014
Priority date	—
Expiry date	Feb 3, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P11/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods, devices and compositions for treatment of severe and uncontrolled asthma are provided by which high amounts of an inhaled corticosteroid are directed to the small airways of the lower lungs. The invention provides for a substantial decrease in the dose of concurrently administered oral corticosteroids. A particular advantage of the invention is the significant reduction in corticosteroid-related adverse effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.